⌘K

Home/Filings/4/0001682873-19-000002

4//SEC Filing

Danielsen Erik 4

Accession 0001682873-19-000002

CIK 0001018735other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 1:09 PM ET

Size

4.4 KB

Accession

0001682873-19-000002

Insider Transaction Report

Form 4

Period: 2018-12-21

NYMOX PHARMACEUTICAL CORPNYMX

Chief Financial Officer

Transactions

Purchase
common stock
2018-12-21$1.35/sh+6,000$8,085→ 20,900 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001682873

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 1:09 PM ET
Size: 4.4 KB

View on SEC.gov